Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Equity Average (2016 - 2025)

Historic Equity Average for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $54.6 million.

  • Fortress Biotech's Equity Average rose 49914.03% to $54.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.6 million, marking a year-over-year increase of 49914.03%. This contributed to the annual value of $22.6 million for FY2024, which is 3760.28% down from last year.
  • As of Q3 2025, Fortress Biotech's Equity Average stood at $54.6 million, which was up 49914.03% from $38.2 million recorded in Q2 2025.
  • Fortress Biotech's Equity Average's 5-year high stood at $246.3 million during Q2 2021, with a 5-year trough of -$14.6 million in Q3 2023.
  • Moreover, its 5-year median value for Equity Average was $38.2 million (2025), whereas its average is $86.1 million.
  • In the last 5 years, Fortress Biotech's Equity Average crashed by 57980.84% in 2024 and then surged by 51224.71% in 2025.
  • Quarter analysis of 5 years shows Fortress Biotech's Equity Average stood at $219.2 million in 2021, then plummeted by 65.47% to $75.7 million in 2022, then crashed by 93.86% to $4.7 million in 2023, then rose by 7.5% to $5.0 million in 2024, then soared by 991.2% to $54.6 million in 2025.
  • Its Equity Average was $54.6 million in Q3 2025, compared to $38.2 million in Q2 2025 and $27.6 million in Q1 2025.